Tag: genomics

PK/PD, Biomarkers & Genomics: Operating Blueprint for Global GCP-Compliant Studies PK/PD, Biomarkers & Genomics: Operating Blueprint for Global GCP-Compliant Studies As the landscape of clinical research continues to evolve, it becomes imperative for professionals engaged in msa clinical trials to maintain compliance with Good Clinical Practice (GCP) and associated regulations governing clinical trials globally, specifically…

Read More “PK/PD, Biomarkers & Genomics: Operating Blueprint for Global GCP-Compliant Studies” »

How to Design PK/PD, Biomarkers & Genomics That Meets FDA, EMA and CLIA/CAP Expectations How to Design PK/PD, Biomarkers & Genomics That Meets FDA, EMA and CLIA/CAP Expectations In the landscape of clinical trials, especially for complex conditions such as non-small cell lung cancer (NSCLC), robust pharmacokinetics (PK) and pharmacodynamics (PD) are paramount. Understanding the…

Read More “How to Design PK/PD, Biomarkers & Genomics That Meets FDA, EMA and CLIA/CAP Expectations” »

PK/PD, Biomarkers & Genomics in Practice: Step-by-Step Guide for Sponsors and CROs PK/PD, Biomarkers & Genomics in Practice: Step-by-Step Guide for Sponsors and CROs In recent years, increasing attention has been given to pharmacokinetics (PK) and pharmacodynamics (PD), biomarkers, and genomics in the realm of clinical research. Sponsors and Contract Research Organizations (CROs) must adopt…

Read More “PK/PD, Biomarkers & Genomics in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in PK/PD, Biomarkers & Genomics—and How to Avoid Data and Safety Risks Common Pitfalls in PK/PD, Biomarkers & Genomics—and How to Avoid Data and Safety Risks In the complex landscape of clinical trials, particularly those involving pharmacokinetics (PK), pharmacodynamics (PD), biomarkers, and genomics, there are numerous data and safety hazards that researchers must…

Read More “Common Pitfalls in PK/PD, Biomarkers & Genomics—and How to Avoid Data and Safety Risks” »

Aligning PK/PD, Biomarkers & Genomics With Protocol, PK/PD and Biomarker Strategies Aligning PK/PD, Biomarkers & Genomics With Protocol, PK/PD and Biomarker Strategies In the rapidly evolving landscape of clinical trials, the integration of pharmacokinetics (PK), pharmacodynamics (PD), biomarkers, and genomic strategies is essential for optimizing study designs and enhancing patient outcomes. This comprehensive tutorial will…

Read More “Aligning PK/PD, Biomarkers & Genomics With Protocol, PK/PD and Biomarker Strategies” »